The acylcarnitine levels of C16 and C18:1 were significantly increased in AML CD34+ cells, largely driven by the presence of FLT3-ITDs, suggesting differences in free fatty acid oxidation in these types of AML (Supplementary Fig. 2a). The gene discussed is FLT3; the disease is acute myeloid leukemia.